nodes	percent_of_prediction	percent_of_DWPC	metapath
Mesoridazine—Propericiazine—ADRA1B—polycystic ovary syndrome	0.00513	0.113	CrCbGaD
Mesoridazine—Acepromazine—ADRA1B—polycystic ovary syndrome	0.00329	0.0728	CrCbGaD
Mesoridazine—Thioproperazine—ADRA1B—polycystic ovary syndrome	0.00322	0.0711	CrCbGaD
Mesoridazine—Propiomazine—ADRA1D—polycystic ovary syndrome	0.00309	0.0682	CrCbGaD
Mesoridazine—Methotrimeprazine—ADRA1D—polycystic ovary syndrome	0.00264	0.0583	CrCbGaD
Mesoridazine—Propiomazine—ADRA1B—polycystic ovary syndrome	0.00263	0.0582	CrCbGaD
Mesoridazine—Thioridazine—ADRA1B—polycystic ovary syndrome	0.00236	0.0521	CrCbGaD
Mesoridazine—Promazine—ADRA1D—polycystic ovary syndrome	0.00229	0.0505	CrCbGaD
Mesoridazine—Methotrimeprazine—ADRA1B—polycystic ovary syndrome	0.00225	0.0497	CrCbGaD
Mesoridazine—Acepromazine—ADRA1A—polycystic ovary syndrome	0.00222	0.049	CrCbGaD
Mesoridazine—Thioproperazine—ADRA1A—polycystic ovary syndrome	0.00217	0.0479	CrCbGaD
Mesoridazine—Promazine—ADRA1B—polycystic ovary syndrome	0.00195	0.0431	CrCbGaD
Mesoridazine—Propiomazine—ADRA1A—polycystic ovary syndrome	0.00177	0.0392	CrCbGaD
Mesoridazine—Chlorpromazine—ADRA1B—polycystic ovary syndrome	0.00172	0.0379	CrCbGaD
Mesoridazine—Thioridazine—ADRA1A—polycystic ovary syndrome	0.00159	0.0351	CrCbGaD
Mesoridazine—Methotrimeprazine—ADRA1A—polycystic ovary syndrome	0.00152	0.0335	CrCbGaD
Mesoridazine—Promethazine—ADRA1A—polycystic ovary syndrome	0.00149	0.033	CrCbGaD
Mesoridazine—Trifluoperazine—ADRA1A—polycystic ovary syndrome	0.00147	0.0325	CrCbGaD
Mesoridazine—Promazine—ADRA1A—polycystic ovary syndrome	0.00131	0.029	CrCbGaD
Mesoridazine—Chlorpromazine—ADRA1A—polycystic ovary syndrome	0.00116	0.0255	CrCbGaD
Mesoridazine—HTR2A—urine—polycystic ovary syndrome	0.000662	0.121	CbGeAlD
Mesoridazine—CYP2D6—urine—polycystic ovary syndrome	0.000603	0.11	CbGeAlD
Mesoridazine—KCNH2—endometrium—polycystic ovary syndrome	0.000234	0.0427	CbGeAlD
Mesoridazine—CHRM2—endocrine gland—polycystic ovary syndrome	0.000227	0.0415	CbGeAlD
Mesoridazine—KCNH2—uterus—polycystic ovary syndrome	0.000216	0.0394	CbGeAlD
Mesoridazine—DRD2—pituitary gland—polycystic ovary syndrome	0.000215	0.0393	CbGeAlD
Mesoridazine—HTR2A—embryo—polycystic ovary syndrome	0.000214	0.0391	CbGeAlD
Mesoridazine—HTR1A—adrenal gland—polycystic ovary syndrome	0.000213	0.0388	CbGeAlD
Mesoridazine—KCNH2—pituitary gland—polycystic ovary syndrome	0.000212	0.0387	CbGeAlD
Mesoridazine—KCNH2—adrenal gland—polycystic ovary syndrome	0.000189	0.0346	CbGeAlD
Mesoridazine—HRH1—endometrium—polycystic ovary syndrome	0.000188	0.0343	CbGeAlD
Mesoridazine—HTR1A—endocrine gland—polycystic ovary syndrome	0.000184	0.0337	CbGeAlD
Mesoridazine—KCNH2—female gonad—polycystic ovary syndrome	0.000176	0.0322	CbGeAlD
Mesoridazine—KCNH2—vagina—polycystic ovary syndrome	0.000175	0.032	CbGeAlD
Mesoridazine—HRH1—adipose tissue—polycystic ovary syndrome	0.000169	0.0309	CbGeAlD
Mesoridazine—DRD2—endocrine gland—polycystic ovary syndrome	0.000167	0.0304	CbGeAlD
Mesoridazine—KCNH2—endocrine gland—polycystic ovary syndrome	0.000164	0.03	CbGeAlD
Mesoridazine—HRH1—adrenal gland—polycystic ovary syndrome	0.000152	0.0277	CbGeAlD
Mesoridazine—HTR2A—pituitary gland—polycystic ovary syndrome	0.000142	0.0259	CbGeAlD
Mesoridazine—HRH1—female gonad—polycystic ovary syndrome	0.000141	0.0258	CbGeAlD
Mesoridazine—HRH1—vagina—polycystic ovary syndrome	0.000141	0.0257	CbGeAlD
Mesoridazine—HRH1—endocrine gland—polycystic ovary syndrome	0.000132	0.024	CbGeAlD
Mesoridazine—HTR2A—adrenal gland—polycystic ovary syndrome	0.000127	0.0231	CbGeAlD
Mesoridazine—HTR2A—Signaling Pathways—RBP4—polycystic ovary syndrome	0.000123	0.00013	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—RBP4—polycystic ovary syndrome	0.000123	0.000129	CbGpPWpGaD
Mesoridazine—HTR6—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.000123	0.000129	CbGpPWpGaD
Mesoridazine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—polycystic ovary syndrome	0.000122	0.000129	CbGpPWpGaD
Mesoridazine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—polycystic ovary syndrome	0.000122	0.000129	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—FGF18—polycystic ovary syndrome	0.000122	0.000128	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling by GPCR—GNAS—polycystic ovary syndrome	0.000121	0.000128	CbGpPWpGaD
Mesoridazine—HRH1—Signaling by GPCR—GNAS—polycystic ovary syndrome	0.000121	0.000127	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—RBP4—polycystic ovary syndrome	0.000121	0.000127	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.000121	0.000127	CbGpPWpGaD
Mesoridazine—DRD3—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.000119	0.000126	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000119	0.000125	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling by GPCR—GNAS—polycystic ovary syndrome	0.000119	0.000125	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000118	0.000125	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000118	0.000124	CbGpPWpGaD
Mesoridazine—HTR2A—vagina—polycystic ovary syndrome	0.000117	0.0214	CbGeAlD
Mesoridazine—HTR1A—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.000117	0.000124	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—YAP1—polycystic ovary syndrome	0.000117	0.000123	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.000117	0.000123	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—PGR—polycystic ovary syndrome	0.000116	0.000122	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—PGR—polycystic ovary syndrome	0.000115	0.000122	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.000115	0.000121	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—GAB1—polycystic ovary syndrome	0.000115	0.000121	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—HMMR—polycystic ovary syndrome	0.000115	0.000121	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—YAP1—polycystic ovary syndrome	0.000115	0.000121	CbGpPWpGaD
Mesoridazine—DRD3—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.000115	0.000121	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—YAP1—polycystic ovary syndrome	0.000115	0.000121	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—GAB1—polycystic ovary syndrome	0.000113	0.000119	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—GAB1—polycystic ovary syndrome	0.000113	0.000119	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—YAP1—polycystic ovary syndrome	0.000113	0.000119	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—GNAS—polycystic ovary syndrome	0.000112	0.000118	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—GAB1—polycystic ovary syndrome	0.000111	0.000117	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—INSR—polycystic ovary syndrome	0.00011	0.000116	CbGpPWpGaD
Mesoridazine—HTR2A—endocrine gland—polycystic ovary syndrome	0.00011	0.0201	CbGeAlD
Mesoridazine—CYP2D6—Metabolism—HSD3B1—polycystic ovary syndrome	0.00011	0.000116	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—NGFR—polycystic ovary syndrome	0.000109	0.000115	CbGpPWpGaD
Mesoridazine—DRD3—Signaling by GPCR—POMC—polycystic ovary syndrome	0.000108	0.000114	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—INSR—polycystic ovary syndrome	0.000108	0.000114	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—INSR—polycystic ovary syndrome	0.000108	0.000114	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—PRL—polycystic ovary syndrome	0.000108	0.000114	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—PLAT—polycystic ovary syndrome	0.000108	0.000114	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—GHRL—polycystic ovary syndrome	0.000108	0.000114	CbGpPWpGaD
Mesoridazine—CYP2D6—female gonad—polycystic ovary syndrome	0.000108	0.0196	CbGeAlD
Mesoridazine—HTR2C—Signaling Pathways—GHRL—polycystic ovary syndrome	0.000107	0.000113	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—PLAT—polycystic ovary syndrome	0.000107	0.000113	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—NCOR1—polycystic ovary syndrome	0.000107	0.000112	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—INSR—polycystic ovary syndrome	0.000106	0.000112	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—NRG1—polycystic ovary syndrome	0.000105	0.00011	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000105	0.00011	CbGpPWpGaD
Mesoridazine—DRD3—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.000104	0.00011	CbGpPWpGaD
Mesoridazine—HTR1A—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.000104	0.00011	CbGpPWpGaD
Mesoridazine—HTR2C—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.000103	0.000109	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.000103	0.000108	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000103	0.000108	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000103	0.000108	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000103	0.000108	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.000102	0.000108	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000102	0.000108	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—PGR—polycystic ovary syndrome	0.000102	0.000107	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.000101	0.000107	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.000101	0.000106	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000101	0.000106	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.0001	0.000106	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—PGR—polycystic ovary syndrome	0.0001	0.000106	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—LHB—polycystic ovary syndrome	0.0001	0.000105	CbGpPWpGaD
Mesoridazine—CYP2D6—endocrine gland—polycystic ovary syndrome	0.0001	0.0183	CbGeAlD
Mesoridazine—HRH1—Signaling Pathways—PGR—polycystic ovary syndrome	0.0001	0.000105	CbGpPWpGaD
Mesoridazine—HTR1A—GPCR downstream signaling—AKT2—polycystic ovary syndrome	9.99e-05	0.000105	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—TCF7L2—polycystic ovary syndrome	9.99e-05	0.000105	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—TNRC6B—polycystic ovary syndrome	9.94e-05	0.000105	CbGpPWpGaD
Mesoridazine—HTR2C—GPCR downstream signaling—AKT2—polycystic ovary syndrome	9.94e-05	0.000105	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—PGR—polycystic ovary syndrome	9.84e-05	0.000104	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—HSD3B2—polycystic ovary syndrome	9.78e-05	0.000103	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—GNAS—polycystic ovary syndrome	9.5e-05	0.0001	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—NGFR—polycystic ovary syndrome	9.5e-05	0.0001	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—AKR1C1—polycystic ovary syndrome	9.48e-05	9.98e-05	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—PLAT—polycystic ovary syndrome	9.47e-05	9.98e-05	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—GHRL—polycystic ovary syndrome	9.47e-05	9.98e-05	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—NGFR—polycystic ovary syndrome	9.45e-05	9.96e-05	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling by GPCR—POMC—polycystic ovary syndrome	9.44e-05	9.94e-05	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—PRL—polycystic ovary syndrome	9.41e-05	9.92e-05	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling by GPCR—POMC—polycystic ovary syndrome	9.39e-05	9.89e-05	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—PRL—polycystic ovary syndrome	9.37e-05	9.87e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—PLAT—polycystic ovary syndrome	9.32e-05	9.82e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—GHRL—polycystic ovary syndrome	9.32e-05	9.82e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—PLAT—polycystic ovary syndrome	9.3e-05	9.8e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—GHRL—polycystic ovary syndrome	9.3e-05	9.8e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—PLAT—polycystic ovary syndrome	9.15e-05	9.64e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—GHRL—polycystic ovary syndrome	9.15e-05	9.64e-05	CbGpPWpGaD
Mesoridazine—DRD2—GPCR downstream signaling—POMC—polycystic ovary syndrome	9.13e-05	9.61e-05	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling by GPCR—AKT2—polycystic ovary syndrome	9.07e-05	9.56e-05	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—NCOR1—polycystic ovary syndrome	9.05e-05	9.54e-05	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—ATF1—polycystic ovary syndrome	9.04e-05	9.52e-05	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling by GPCR—AKT2—polycystic ovary syndrome	9.03e-05	9.51e-05	CbGpPWpGaD
Mesoridazine—HTR2A—GPCR downstream signaling—POMC—polycystic ovary syndrome	8.98e-05	9.46e-05	CbGpPWpGaD
Mesoridazine—HRH1—GPCR downstream signaling—POMC—polycystic ovary syndrome	8.96e-05	9.44e-05	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—IRS2—polycystic ovary syndrome	8.96e-05	9.44e-05	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—ADRB2—polycystic ovary syndrome	8.93e-05	9.41e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—ATF1—polycystic ovary syndrome	8.89e-05	9.37e-05	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—NRG1—polycystic ovary syndrome	8.89e-05	9.36e-05	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—ADRB2—polycystic ovary syndrome	8.89e-05	9.36e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—ATF1—polycystic ovary syndrome	8.87e-05	9.35e-05	CbGpPWpGaD
Mesoridazine—CHRM2—GPCR downstream signaling—POMC—polycystic ovary syndrome	8.82e-05	9.29e-05	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—TCF7L2—polycystic ovary syndrome	8.81e-05	9.28e-05	CbGpPWpGaD
Mesoridazine—DRD2—GPCR downstream signaling—AKT2—polycystic ovary syndrome	8.77e-05	9.24e-05	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—LEP—polycystic ovary syndrome	8.77e-05	9.24e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—ATF1—polycystic ovary syndrome	8.73e-05	9.2e-05	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—SULT2A1—polycystic ovary syndrome	8.72e-05	9.19e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—TCF7L2—polycystic ovary syndrome	8.67e-05	9.14e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—TCF7L2—polycystic ovary syndrome	8.65e-05	9.12e-05	CbGpPWpGaD
Mesoridazine—HTR2A—GPCR downstream signaling—AKT2—polycystic ovary syndrome	8.63e-05	9.09e-05	CbGpPWpGaD
Mesoridazine—HRH1—GPCR downstream signaling—AKT2—polycystic ovary syndrome	8.61e-05	9.07e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—TCF7L2—polycystic ovary syndrome	8.51e-05	8.97e-05	CbGpPWpGaD
Mesoridazine—CHRM2—GPCR downstream signaling—AKT2—polycystic ovary syndrome	8.47e-05	8.93e-05	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—RRM2—polycystic ovary syndrome	8.45e-05	8.9e-05	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—NGFR—polycystic ovary syndrome	8.34e-05	8.79e-05	CbGpPWpGaD
Mesoridazine—DRD2—Signaling by GPCR—POMC—polycystic ovary syndrome	8.29e-05	8.73e-05	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—GNAS—polycystic ovary syndrome	8.28e-05	8.72e-05	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—PRL—polycystic ovary syndrome	8.27e-05	8.71e-05	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—GNAS—polycystic ovary syndrome	8.24e-05	8.68e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—NGFR—polycystic ovary syndrome	8.21e-05	8.65e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—NGFR—polycystic ovary syndrome	8.19e-05	8.63e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling by GPCR—POMC—polycystic ovary syndrome	8.15e-05	8.59e-05	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—YAP1—polycystic ovary syndrome	8.14e-05	8.58e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling by GPCR—POMC—polycystic ovary syndrome	8.14e-05	8.57e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—PRL—polycystic ovary syndrome	8.13e-05	8.57e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—PRL—polycystic ovary syndrome	8.12e-05	8.55e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—NGFR—polycystic ovary syndrome	8.06e-05	8.49e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling by GPCR—POMC—polycystic ovary syndrome	8.01e-05	8.43e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—PRL—polycystic ovary syndrome	7.99e-05	8.41e-05	CbGpPWpGaD
Mesoridazine—DRD2—Signaling by GPCR—AKT2—polycystic ovary syndrome	7.97e-05	8.39e-05	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—NCOR1—polycystic ovary syndrome	7.89e-05	8.31e-05	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—NCOR1—polycystic ovary syndrome	7.85e-05	8.27e-05	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—ADRB2—polycystic ovary syndrome	7.84e-05	8.26e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling by GPCR—AKT2—polycystic ovary syndrome	7.84e-05	8.26e-05	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—IRS1—polycystic ovary syndrome	7.82e-05	8.24e-05	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—NAMPT—polycystic ovary syndrome	7.82e-05	8.24e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling by GPCR—AKT2—polycystic ovary syndrome	7.82e-05	8.24e-05	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—NRG1—polycystic ovary syndrome	7.74e-05	8.16e-05	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—CYP11A1—polycystic ovary syndrome	7.72e-05	8.14e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—ADRB2—polycystic ovary syndrome	7.72e-05	8.13e-05	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—NRG1—polycystic ovary syndrome	7.7e-05	8.12e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—ADRB2—polycystic ovary syndrome	7.7e-05	8.11e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling by GPCR—AKT2—polycystic ovary syndrome	7.7e-05	8.11e-05	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—IRS2—polycystic ovary syndrome	7.61e-05	8.02e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—ADRB2—polycystic ovary syndrome	7.58e-05	7.98e-05	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—POMC—polycystic ovary syndrome	7.53e-05	7.94e-05	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—INS—polycystic ovary syndrome	7.49e-05	7.89e-05	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—LEP—polycystic ovary syndrome	7.45e-05	7.85e-05	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—AKR1C3—polycystic ovary syndrome	7.29e-05	7.68e-05	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—GNAS—polycystic ovary syndrome	7.27e-05	7.66e-05	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—IGF1—polycystic ovary syndrome	7.25e-05	7.63e-05	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—AKT2—polycystic ovary syndrome	7.24e-05	7.63e-05	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—CYP17A1—polycystic ovary syndrome	7.18e-05	7.56e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—GNAS—polycystic ovary syndrome	7.15e-05	7.54e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—GNAS—polycystic ovary syndrome	7.14e-05	7.52e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—GNAS—polycystic ovary syndrome	7.02e-05	7.4e-05	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—NCOR1—polycystic ovary syndrome	6.93e-05	7.3e-05	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—SERPINE1—polycystic ovary syndrome	6.88e-05	7.25e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—NCOR1—polycystic ovary syndrome	6.82e-05	7.18e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—NCOR1—polycystic ovary syndrome	6.8e-05	7.16e-05	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—NRG1—polycystic ovary syndrome	6.8e-05	7.16e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—NCOR1—polycystic ovary syndrome	6.69e-05	7.05e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—NRG1—polycystic ovary syndrome	6.69e-05	7.05e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—NRG1—polycystic ovary syndrome	6.68e-05	7.03e-05	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—IRS1—polycystic ovary syndrome	6.64e-05	7e-05	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—IRS2—polycystic ovary syndrome	6.63e-05	6.99e-05	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—IRS2—polycystic ovary syndrome	6.6e-05	6.95e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—NRG1—polycystic ovary syndrome	6.57e-05	6.92e-05	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—LEP—polycystic ovary syndrome	6.49e-05	6.84e-05	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—LEP—polycystic ovary syndrome	6.46e-05	6.8e-05	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—POMC—polycystic ovary syndrome	6.4e-05	6.74e-05	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—INS—polycystic ovary syndrome	6.36e-05	6.7e-05	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—TH—polycystic ovary syndrome	6.21e-05	6.55e-05	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—IGF1—polycystic ovary syndrome	6.15e-05	6.48e-05	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—AKT2—polycystic ovary syndrome	6.15e-05	6.48e-05	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—SLC2A4—polycystic ovary syndrome	6.04e-05	6.37e-05	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—SERPINE1—polycystic ovary syndrome	5.84e-05	6.16e-05	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—IRS2—polycystic ovary syndrome	5.82e-05	6.13e-05	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—IRS1—polycystic ovary syndrome	5.79e-05	6.1e-05	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—IRS1—polycystic ovary syndrome	5.76e-05	6.07e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—IRS2—polycystic ovary syndrome	5.73e-05	6.04e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—IRS2—polycystic ovary syndrome	5.72e-05	6.02e-05	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—LEP—polycystic ovary syndrome	5.7e-05	6e-05	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—CYP19A1—polycystic ovary syndrome	5.68e-05	5.99e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—IRS2—polycystic ovary syndrome	5.63e-05	5.93e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—LEP—polycystic ovary syndrome	5.61e-05	5.91e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—LEP—polycystic ovary syndrome	5.6e-05	5.89e-05	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—POMC—polycystic ovary syndrome	5.58e-05	5.87e-05	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—POMC—polycystic ovary syndrome	5.55e-05	5.84e-05	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—INS—polycystic ovary syndrome	5.55e-05	5.84e-05	CbGpPWpGaD
Mesoridazine—HTR6—Signaling by GPCR—IL6—polycystic ovary syndrome	5.54e-05	5.84e-05	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—INS—polycystic ovary syndrome	5.52e-05	5.81e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—LEP—polycystic ovary syndrome	5.51e-05	5.8e-05	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—IGF1—polycystic ovary syndrome	5.36e-05	5.65e-05	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—AKT2—polycystic ovary syndrome	5.36e-05	5.65e-05	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—IGF1—polycystic ovary syndrome	5.34e-05	5.62e-05	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—AKT2—polycystic ovary syndrome	5.33e-05	5.62e-05	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—SERPINE1—polycystic ovary syndrome	5.09e-05	5.37e-05	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—IRS1—polycystic ovary syndrome	5.08e-05	5.36e-05	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—GNAS—polycystic ovary syndrome	5.07e-05	5.34e-05	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—SERPINE1—polycystic ovary syndrome	5.07e-05	5.34e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—IRS1—polycystic ovary syndrome	5e-05	5.27e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—IRS1—polycystic ovary syndrome	4.99e-05	5.26e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—IRS1—polycystic ovary syndrome	4.91e-05	5.17e-05	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—POMC—polycystic ovary syndrome	4.9e-05	5.16e-05	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—INS—polycystic ovary syndrome	4.87e-05	5.13e-05	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—NCOR1—polycystic ovary syndrome	4.83e-05	5.09e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—POMC—polycystic ovary syndrome	4.82e-05	5.07e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—POMC—polycystic ovary syndrome	4.81e-05	5.06e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—INS—polycystic ovary syndrome	4.79e-05	5.05e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—INS—polycystic ovary syndrome	4.78e-05	5.04e-05	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—VEGFA—polycystic ovary syndrome	4.73e-05	4.99e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—POMC—polycystic ovary syndrome	4.73e-05	4.98e-05	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—IGF1—polycystic ovary syndrome	4.71e-05	4.96e-05	CbGpPWpGaD
Mesoridazine—DRD3—Signaling by GPCR—IL6—polycystic ovary syndrome	4.71e-05	4.96e-05	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—AKT2—polycystic ovary syndrome	4.71e-05	4.96e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—INS—polycystic ovary syndrome	4.7e-05	4.96e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—IGF1—polycystic ovary syndrome	4.63e-05	4.88e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—AKT2—polycystic ovary syndrome	4.63e-05	4.88e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—IGF1—polycystic ovary syndrome	4.62e-05	4.87e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—AKT2—polycystic ovary syndrome	4.62e-05	4.87e-05	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—CYP1A1—polycystic ovary syndrome	4.58e-05	4.83e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—IGF1—polycystic ovary syndrome	4.55e-05	4.79e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—AKT2—polycystic ovary syndrome	4.55e-05	4.79e-05	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—SERPINE1—polycystic ovary syndrome	4.47e-05	4.71e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—SERPINE1—polycystic ovary syndrome	4.4e-05	4.64e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—SERPINE1—polycystic ovary syndrome	4.39e-05	4.63e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—SERPINE1—polycystic ovary syndrome	4.32e-05	4.55e-05	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—MTHFR—polycystic ovary syndrome	4.27e-05	4.5e-05	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling by GPCR—IL6—polycystic ovary syndrome	4.1e-05	4.32e-05	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling by GPCR—IL6—polycystic ovary syndrome	4.08e-05	4.3e-05	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—VEGFA—polycystic ovary syndrome	4.02e-05	4.23e-05	CbGpPWpGaD
Mesoridazine—DRD2—Signaling by GPCR—IL6—polycystic ovary syndrome	3.6e-05	3.79e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling by GPCR—IL6—polycystic ovary syndrome	3.54e-05	3.73e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling by GPCR—IL6—polycystic ovary syndrome	3.54e-05	3.72e-05	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—VEGFA—polycystic ovary syndrome	3.5e-05	3.69e-05	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—VEGFA—polycystic ovary syndrome	3.49e-05	3.67e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling by GPCR—IL6—polycystic ovary syndrome	3.48e-05	3.67e-05	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—PPARG—polycystic ovary syndrome	3.46e-05	3.65e-05	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—POMC—polycystic ovary syndrome	3.42e-05	3.6e-05	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—INS—polycystic ovary syndrome	3.4e-05	3.58e-05	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—IL6—polycystic ovary syndrome	3.27e-05	3.45e-05	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—VEGFA—polycystic ovary syndrome	3.08e-05	3.24e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—VEGFA—polycystic ovary syndrome	3.03e-05	3.19e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—VEGFA—polycystic ovary syndrome	3.02e-05	3.18e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—VEGFA—polycystic ovary syndrome	2.97e-05	3.13e-05	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—IL6—polycystic ovary syndrome	2.78e-05	2.93e-05	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—IL6—polycystic ovary syndrome	2.42e-05	2.55e-05	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—IL6—polycystic ovary syndrome	2.41e-05	2.54e-05	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—IL6—polycystic ovary syndrome	2.13e-05	2.24e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—IL6—polycystic ovary syndrome	2.09e-05	2.21e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—IL6—polycystic ovary syndrome	2.09e-05	2.2e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—IL6—polycystic ovary syndrome	2.06e-05	2.17e-05	CbGpPWpGaD
